Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]

3373 reported adverse events

Drugs of this class: BEMPEDOIC ACID BEMPEDOIC ACID AND EZETIMIBE

These side effects are most commonly reported by patients taking drugs of the Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] class:

# Side effect Count
0 MYALGIA 468
1 ARTHRALGIA 315
2 PAIN IN EXTREMITY 208
3 MUSCLE SPASMS 207
4 NAUSEA 176
5 FATIGUE 172
6 DIZZINESS 168
7 HEADACHE 159
8 DIARRHOEA 151
9 PAIN 107
See all common reactions for Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]

Drugs of the Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 GLUCOSE URINE 9 0.0600
1 RENAL HYPERTENSION 9 0.0289
2 LIPOPROTEIN (A) INCREASED 9 0.0275
3 CHRONIC HEPATITIS C 9 0.0228
4 BLOOD URIC ACID ABNORMAL 8 0.0196
5 MUSCLE DISCOMFORT 15 0.0191
6 HYPERTENSIVE URGENCY 8 0.0144
7 BLOOD URIC ACID INCREASED 67 0.0116
8 RETICULOCYTE COUNT INCREASED 9 0.0111
9 NECROTISING MYOSITIS 9 0.0104
See all enriched reactions for Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC]